316 related articles for article (PubMed ID: 25274816)
1. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.
Wong R; Schlichter LC
J Neurosci; 2014 Oct; 34(40):13371-83. PubMed ID: 25274816
[TBL] [Abstract][Full Text] [Related]
2. KCa3.1/IK1 Channel Regulation by cGMP-Dependent Protein Kinase (PKG) via Reactive Oxygen Species and CaMKII in Microglia: An Immune Modulating Feedback System?
Ferreira R; Wong R; Schlichter LC
Front Immunol; 2015; 6():153. PubMed ID: 25904916
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells.
Ferreira R; Schlichter LC
PLoS One; 2013; 8(4):e62345. PubMed ID: 23620825
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process.
Morales P; Garneau L; Klein H; Lavoie MF; Parent L; Sauvé R
J Gen Physiol; 2013 Jul; 142(1):37-60. PubMed ID: 23797421
[TBL] [Abstract][Full Text] [Related]
5. The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration.
Kaushal V; Koeberle PD; Wang Y; Schlichter LC
J Neurosci; 2007 Jan; 27(1):234-44. PubMed ID: 17202491
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
Bouhy D; Ghasemlou N; Lively S; Redensek A; Rathore KI; Schlichter LC; David S
J Neurosci; 2011 Nov; 31(45):16298-308. PubMed ID: 22072681
[TBL] [Abstract][Full Text] [Related]
7. Channelopathy of small- and intermediate-conductance Ca
Nam YW; Downey M; Rahman MA; Cui M; Zhang M
Acta Pharmacol Sin; 2023 Feb; 44(2):259-267. PubMed ID: 35715699
[TBL] [Abstract][Full Text] [Related]
8. The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling.
Bi D; Toyama K; Lemaître V; Takai J; Fan F; Jenkins DP; Wulff H; Gutterman DD; Park F; Miura H
J Biol Chem; 2013 May; 288(22):15843-53. PubMed ID: 23609438
[TBL] [Abstract][Full Text] [Related]
9. Structure, Gating and Basic Functions of the Ca2+-activated K Channel of Intermediate Conductance.
Sforna L; Megaro A; Pessia M; Franciolini F; Catacuzzeno L
Curr Neuropharmacol; 2018; 16(5):608-617. PubMed ID: 28875832
[TBL] [Abstract][Full Text] [Related]
10. Laminar shear stress upregulates endothelial Ca²⁺-activated K⁺ channels KCa2.3 and KCa3.1 via a Ca²⁺/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
Takai J; Santu A; Zheng H; Koh SD; Ohta M; Filimban LM; Lemaître V; Teraoka R; Jo H; Miura H
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H484-93. PubMed ID: 23792675
[TBL] [Abstract][Full Text] [Related]
11. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
[TBL] [Abstract][Full Text] [Related]
12. Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K
Burg S; Shapiro S; Peretz A; Haimov E; Redko B; Yeheskel A; Simhaev L; Engel H; Raveh A; Ben-Bassat A; Murninkas M; Polak R; Haitin Y; Etzion Y; Attali B
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2202926119. PubMed ID: 35969786
[TBL] [Abstract][Full Text] [Related]
13. Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.
Duffy SM; Cruse G; Brightling CE; Bradding P
Eur J Immunol; 2007 Jun; 37(6):1653-62. PubMed ID: 17474152
[TBL] [Abstract][Full Text] [Related]
14. The stimulating effects of nitric oxide on intermediate conductance Ca²⁺-activated K⁺ channels in human dermal fibroblasts through PKG pathways but not the PKA pathways.
Bae H; Lee HJ; Kim K; Kim JH; Kim T; Ko JH; Bang H; Lim I
Chin J Physiol; 2014 Jun; 57(3):137-51. PubMed ID: 24826782
[TBL] [Abstract][Full Text] [Related]
15. Investigating the Impact of Electrostatic Interactions on Calmodulin Binding and Ca
Segura É; Zhao J; Broszczak M; Audet F; Sauvé R; Parent L
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673845
[TBL] [Abstract][Full Text] [Related]
16. KCa3.1 Channels and Glioblastoma: In Vitro Studies.
Klumpp L; Sezgin EC; Skardelly M; Eckert F; Huber SM
Curr Neuropharmacol; 2018; 16(5):627-635. PubMed ID: 28786347
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.
Srivastava S; Choudhury P; Li Z; Liu G; Nadkarni V; Ko K; Coetzee WA; Skolnik EY
Mol Biol Cell; 2006 Jan; 17(1):146-54. PubMed ID: 16251351
[TBL] [Abstract][Full Text] [Related]
18. Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-
Brown BM; Shim H; Zhang M; Yarov-Yarovoy V; Wulff H
Mol Pharmacol; 2017 Oct; 92(4):469-480. PubMed ID: 28760780
[TBL] [Abstract][Full Text] [Related]
19. Calcium-gated K
Tarasov MV; Bystrova MF; Kotova PD; Rogachevskaja OA; Sysoeva VY; Kolesnikov SS
Pflugers Arch; 2017 Feb; 469(2):349-362. PubMed ID: 28028617
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of KCa3.1 by depolarisation and 2-aminoethoxydiphenyl borate (2-APB) during Ca²⁺ release activated Ca²⁺ (CRAC) entry in human erythroleukemia (HEL) cells: Implications for the interpretation of 2-APB inhibition of CRAC entry.
Littlechild R; Zaidman N; Khodaverdi D; Mason MJ
Cell Calcium; 2015 Feb; 57(2):76-88. PubMed ID: 25601026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
